Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Cross ShawnChief Financial Officer | Option exercise · 10b5-1 plan | M | — 2,845 sh | Apr 22, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 33.3K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion · 10b5-1 plan | C | — 225.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Cross ShawnChief Financial Officer | Option exercise · 10b5-1 plan | M | — 7,714 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Hyep IvanChief Financial Officer | Option exercise · 10b5-1 plan | M | $35K 9,200 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 33.3K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion · 10b5-1 plan | C | — 225.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 12.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Capital V LLC10% Owner | Disposition to issuer · 10b5-1 plan | D | — 37.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 33.3K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 12.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Adarkar PrabirPRESIDENT AND COO | Option exercise · 10b5-1 plan | M | — 10.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Adarkar PrabirPRESIDENT AND COO | Grant or award · 10b5-1 plan | A | — 144.3K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Adarkar PrabirPRESIDENT AND COO | Option exercise · 10b5-1 plan | M | $72K 10.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | Option exercise · 10b5-1 plan | M | — 12.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | Option exercise · 10b5-1 plan | M | — 12.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 200.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 33.3K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Cross ShawnChief Financial Officer | Option exercise · 10b5-1 plan | M | $25K 1,500 sh | Apr 22, 2026 traded Apr 22, 2026 |
| 0 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | Disposition to issuer · 10b5-1 plan | D | — 12.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion · 10b5-1 plan | C | — 900.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 54.2K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion · 10b5-1 plan | C | — 900.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | Derivative conversion · 10b5-1 plan | C | — 33.3K sh | Apr 22, 2026 traded Apr 21, 2026 |
| 0 | Arora TarunChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $41K 953 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 0 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | Option exercise · 10b5-1 plan | M | — 12.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Okupe OluyemiChief Financial Officer | Option exercise · 10b5-1 plan | M | $81K 7,000 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Okupe OluyemiChief Financial Officer | Option exercise · 10b5-1 plan | M | $28K 5,553 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | Disposition to issuer · 10b5-1 plan | D | — 12.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | Option exercise · 10b5-1 plan | M | — 12.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Capital V LLC10% Owner | Option exercise · 10b5-1 plan | M | — 37.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 54.2K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Capital V LLC10% Owner | Option exercise · 10b5-1 plan | M | — 37.5K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Cross ShawnChief Financial Officer | Option exercise · 10b5-1 plan | M | — 1,500 sh | Apr 22, 2026 traded Apr 22, 2026 |
| 0 | Okupe OluyemiChief Financial Officer | Option exercise · 10b5-1 plan | M | — 7,000 sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Sehmi HarminderChief Financial Officer | Option exercise · 10b5-1 plan | M | — 505.1K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Cross ShawnChief Financial Officer | Option exercise · 10b5-1 plan | M | $47K 2,845 sh | Apr 22, 2026 traded Apr 21, 2026 |
| 0 | Venker EricPresident & Immunovant CEO | Option exercise · 10b5-1 plan | M | — 200.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | Derivative conversion · 10b5-1 plan | C | — 33.3K sh | Apr 22, 2026 traded Apr 21, 2026 |
| 0 | Okupe OluyemiChief Financial Officer | Option exercise · 10b5-1 plan | M | — 5,553 sh | Apr 22, 2026 traded Apr 20, 2026 |